OrthoPediatrics (KIDS) Stock Price, News & Analysis

Company Overview

OrthoPediatrics (NASDAQ: KIDS) is a medical device company dedicated exclusively to pediatric orthopedics, developing specialized implants and instruments designed to meet the unique anatomical and physiological needs of children. Headquartered in Warsaw, Indiana—often referred to as the “Orthopedic Capital of the World”—the company focuses on addressing conditions such as fractures, deformities, and congenital disorders through innovative solutions tailored for growing patients.

The company’s product portfolio spans multiple clinical areas, including trauma and deformity, spine, sports medicine, and foot and ankle. OrthoPediatrics offers a range of small-profile plates, screws, nails and rods, as well as dedicated instrumentation and surgical navigation systems. Each offering is engineered to provide optimized fixation and correction in pediatric applications, drawing from adult implant technology but scaled down to enhance surgical precision, reduce soft tissue disruption and support healthier long-term outcomes for young patients.

Founded in 2006, OrthoPediatrics has expanded its operations through organic growth and strategic collaborations, culminating in a public listing in December 2017. The company maintains an international footprint with offices and subsidiaries across Europe, Latin America, Canada, Australia, New Zealand and select markets in Asia. Partnerships with leading pediatric orthopedic surgeons and academic centers drive its research and development efforts, while a global distributor network ensures broad access to its full product line.

Leadership at OrthoPediatrics combines deep orthopedic experience with medical device commercialization expertise. Under the direction of CEO Mike Allegrezza and a management team that includes seasoned professionals in finance, operations and clinical affairs, the company continues to invest in new product innovation, surgeon training programs and evidence-based studies. Its ongoing commitment to pediatric orthopedic care underscores a mission to improve the quality of life for children worldwide.

Key Stats

• Today's Range: $21.91 to $22.55
• 50-Day Range: $19.96 to $23.27
• 52-Week Range: $19.52 to $35.99
• Volume: 90,392 shs
• Average Volume: 199,192 shs
• Market Capitalization: $545.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $35.83
• Consensus Rating: Moderate Buy

OrthoPediatrics Stock Analysis - MarketRank™

OrthoPediatrics scored higher than 78% of companies evaluated by MarketBeat, and ranked 221st out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

OrthoPediatrics has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

OrthoPediatrics has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for OrthoPediatrics are expected to grow in the coming year, from ($0.93) to ($0.86) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of OrthoPediatrics is -12.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of OrthoPediatrics is -12.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

OrthoPediatrics has a P/B Ratio of 1.53. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.71% of the float of OrthoPediatrics has been sold short.

Short Interest Ratio / Days to Cover

OrthoPediatrics has a short interest ratio ("days to cover") of 7.6.

Change versus previous month

Short interest in OrthoPediatrics has recently decreased by 0.90%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

OrthoPediatrics does not currently pay a dividend.

Dividend Growth

OrthoPediatrics does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.9 / 5
• Environmental Score: -1.20

Percentage of Shares Shorted

6.71% of the float of OrthoPediatrics has been sold short.

Short Interest Ratio / Days to Cover

OrthoPediatrics has a short interest ratio ("days to cover") of 7.6.

Change versus previous month

Short interest in OrthoPediatrics has recently decreased by 0.90%, indicating that investor sentiment is improving.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for OrthoPediatrics this week, compared to 2 articles on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, OrthoPediatrics insiders have not sold or bought any company stock.

Percentage Held by Insiders

32.70% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

69.05% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

KIDS Stock Analysis - Frequently Asked Questions

How have KIDS shares performed this year?

OrthoPediatrics' stock was trading at $23.18 on January 1st, 2025. Since then, KIDS stock has decreased by 3.1% and is now trading at $22.4650.

How were OrthoPediatrics' earnings last quarter?

OrthoPediatrics Corp. (NASDAQ:KIDS) announced its quarterly earnings results on Wednesday, May, 7th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.13. The company earned $52.41 million during the quarter, compared to analyst estimates of $51.68 million. OrthoPediatrics had a negative net margin of 19.15% and a negative trailing twelve-month return on equity of 7.03%.
Read the conference call transcript.

When did OrthoPediatrics IPO?

OrthoPediatrics (KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.

How do I buy shares of OrthoPediatrics?

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of OrthoPediatrics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that OrthoPediatrics investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

• Last Earnings: 5/07/2025
• Today: 7/06/2025
• Next Earnings (Estimated): 8/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:KIDS
• CIK: 1425450
• Web: www.orthopediatrics.com
• Phone: (574) 268-6379
• Fax: 574-269-3692
• Employees: 200
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $35.83
• High Stock Price Target: $50.00
• Low Stock Price Target: $24.00
• Potential Upside/Downside: +59.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.75)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$37.82 million
• Net Margins: -19.15%
• Pretax Margin: -19.80%
• Return on Equity: -7.03%
• Return on Assets: -5.45%

Debt

• Debt-to-Equity Ratio: 0.21
• Current Ratio: 6.19
• Quick Ratio: 2.99

Sales & Book Value

• Annual Sales: $212.45 million
• Price / Sales: 2.57
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $14.64 per share
• Price / Book: 1.53

Miscellaneous

• Outstanding Shares: 24,287,000
• Free Float: 16,345,000
• Market Cap: $545.61 million
• Optionable: Optionable
• Beta: 1.10